Dynasil Announces Approval of Key Patents for Medical Imaging and Detecting Nuclear Materials

WATERTOWN, Mass.--(BUSINESS WIRE)--Dynasil Corporation (NASDAQ:DYSL), a leader in specialized sensors, precision instruments and optical products for the medical, industrial and homeland security/defense markets, today announced that its subsidiary, Radiation Monitoring Devices, Inc. (RMD) was granted eleven individual patents by the United States Patent and Trademark Office (USPTO) during 2010 relating to new scintillation materials for improved nuclear material detection and medical imaging applications. These patents cover technology that can help protect the public against the risk of nuclear terrorism by providing greater sensitivity in security scanning systems. The same technology can also help doctors improve patient outcomes, such as by more accurately locating cancer cells for targeted therapy through higher resolution medical imaging, with lower radiation doses.